1-9 of 9
Michael Feigh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

1642-P: Metabolic Effects of Semaglutide and Resmetirom at Thermoneutrality in the Diet-Induced Obese Mouse

MARCO TOZZI, MICHAEL FEIGH, HENRIK H. HANSEN
Journal: Diabetes
Diabetes 2024;73(Supplement_1):1642-P
https://doi.org/10.2337/db24-1642-P
Published: 14 June 2024
View articletitled, 1642-P: Metabolic Effects of Semaglutide and Resmetirom at Thermoneutrality in the Diet-Induced Obese Mouse
Meeting Abstracts

106-OR: Semaglutide Reduces Tumor Burden in the GAN Diet-Induced Obese and Biopsy-Confirmed Mouse Model of MASH with Advanced Fibrosis and HCC

MICHAEL FEIGH, MARCO TOZZI, HENRIK H. HANSEN
Journal: Diabetes
Diabetes 2024;73(Supplement_1):106-OR
https://doi.org/10.2337/db24-106-OR
Published: 14 June 2024
View articletitled, 106-OR: Semaglutide Reduces Tumor Burden in the GAN Diet-Induced Obese and Biopsy-Confirmed Mouse Model of MASH with Advanced Fibrosis and HCC
Meeting Abstracts

760-P: TERN-501 Enhances Weight Loss Efficacy of a GLP-1R Agonist in Obese Mice via Increased Fat Mass Loss without Additional Loss of Lean Mass

CHRISTOPHER JONES, OLIVIA OSBORN, KEVIN P. QUINN, MICHAEL FEIGH, ANDREAS NYGAARD MADSEN, JEFFREY R. JASPER
Journal: Diabetes
Diabetes 2024;73(Supplement_1):760-P
https://doi.org/10.2337/db24-760-P
Published: 14 June 2024
View articletitled, 760-P: TERN-501 Enhances Weight Loss Efficacy of a GLP-1R Agonist in Obese Mice via Increased Fat Mass Loss without Additional Loss of Lean Mass
Meeting Abstracts

1810-P: Triple Combination Therapy of GLP-1 Receptor Agonist Semaglutide with an FXR Agonist and AC Inhibitor Reverses Nonalcoholic Steatohepatitis (NASH) in Diet-Induced and Biopsy-Confirmed Mice

JENNY NORLIN, DIEGO A. MIRANDA, JAMIE G. BATES, NORA E. ZOIS, SANNE VEIDAL, MICHAEL FEIGH, JAMES L. TREVASKIS, MARKUS LATTA
Journal: Diabetes
Diabetes 2020;69(Supplement_1):1810-P
https://doi.org/10.2337/db20-1810-P
Published: 01 June 2020
View articletitled, 1810-P: Triple Combination Therapy of GLP-1 Receptor Agonist Semaglutide with an FXR Agonist and AC Inhibitor Reverses Nonalcoholic Steatohepatitis (NASH) in Diet-Induced and Biopsy-Confirmed Mice
Meeting Abstracts

1813-P: Coadministration of a GLP-1/Glucagon Receptor Agonist with an FXR Agonist and ACC Inhibitor Reverses Nonalcoholic Steatohepatitis (NASH) in Diet-Induced and Biopsy-Confirmed Mice

JAMES L. TREVASKIS, JENNY NORLIN, DIEGO A. MIRANDA, JAMIE G. BATES, NORA E. ZOIS, SANNE VEIDAL, MICHAEL FEIGH, MARKUS LATTA
Journal: Diabetes
Diabetes 2020;69(Supplement_1):1813-P
https://doi.org/10.2337/db20-1813-P
Published: 01 June 2020
View articletitled, 1813-P: Coadministration of a GLP-1/Glucagon Receptor Agonist with an FXR Agonist and ACC Inhibitor Reverses Nonalcoholic Steatohepatitis (NASH) in Diet-Induced and Biopsy-Confirmed Mice
Meeting Abstracts

2020-P: Comparable Disease Progression in GAN and AMLN Diet-Induced Obese Mouse Models of Biopsy-Confirmed Nonalcoholic Steatohepatitis

BRANDON B. BOLAND, HENRIK H. HANSEN, MICHELLE BOLAND, DENISE ORÓ, KIRSTINE SLOTH TØLBØL, SANNE VEIDAL, MICHAEL FEIGH, JACOB JELSING, NIELS VRANG, JAMES TREVASKIS
Journal: Diabetes
Diabetes 2019;68(Supplement_1):2020-P
https://doi.org/10.2337/db19-2020-P
Published: 01 June 2019
View articletitled, 2020-P: Comparable Disease Progression in GAN and AMLN Diet-Induced Obese Mouse Models of Biopsy-Confirmed Nonalcoholic Steatohepatitis
Meeting Abstracts

ZGN-1061, a Novel MetAP2 Inhibitor, and Liraglutide Combine to Improve Glycemic Control and Reduce Body Weight in a Rat Model of Diet-Induced Obesity

BRYAN F. BURKEY, PHILIP J. PEDERSEN, TANJA X. PEDERSEN, MICHAEL FEIGH, JAMES VATH, THOMAS E. HUGHES
Journal: Diabetes
Diabetes 2018;67(Supplement_1):108-LB
https://doi.org/10.2337/db18-108-LB
Published: 01 July 2018
View articletitled, ZGN-1061, a Novel MetAP2 Inhibitor, and Liraglutide Combine to Improve Glycemic Control and Reduce Body Weight in a Rat Model of Diet-Induced Obesity
Meeting Abstracts

ZGN-1061 Improves Metabolic Parameters and Hepatic Pathology in an Obese Mouse Model of Diet-Induced and Biopsy-Confirmed Nonalcoholic Steatohepatitis

BRYAN F. BURKEY, MARTIN ILLEMANN, SANNE VEIDAL, MICHAEL FEIGH, JAMES VATH, THOMAS E. HUGHES
Journal: Diabetes
Diabetes 2018;67(Supplement_1):107-LB
https://doi.org/10.2337/db18-107-LB
Published: 01 July 2018
View articletitled, ZGN-1061 Improves Metabolic Parameters and Hepatic Pathology in an Obese Mouse Model of Diet-Induced and Biopsy-Confirmed Nonalcoholic Steatohepatitis
Journal Articles

Neurturin and a GLP-1 Analogue Act Synergistically to Alleviate Diabetes in Zucker Diabetic Fatty Rats

James L. Trevaskis, Chester Bittencourt Sacramento, Hani Jouihan, Safina Ali, John Le Lay, Stephanie Oldham, Nicholas Bhagroo, Brandon B. Boland, Jennifer Cann, Yuan Chang, Terrence O’Day, Victor Howard, Christina Reers, Maria Sorhede Winzell, David M. Smith, Michael Feigh, Pernille Barkholt, Kay Schreiter, Matthias Austen, Uwe Andag, Simon Thompson, Lutz Jermutus, Matthew P. Coghlan, Joseph Grimsby, Cord Dohrmann, Christopher J. Rhodes, Cristina M. Rondinone, Arun Sharma
Journal: Diabetes
Diabetes 2017;66(7):2007–2018
https://doi.org/10.2337/db16-0916
Published: 13 April 2017
View articletitled, Neurturin and a GLP-1 Analogue Act Synergistically to Alleviate Diabetes in Zucker Diabetic Fatty Rats
Open the PDF for Neurturin and a GLP-1 Analogue Act Synergistically to Alleviate Diabetes in Zucker Diabetic Fatty Rats in another window
Includes: Supplementary data